nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP3A4—Temozolomide—melanoma	0.13	0.229	CbGbCtD
Oxycodone—CYP2D6—Vemurafenib—melanoma	0.112	0.197	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0836	0.147	CbGbCtD
Oxycodone—CYP3A7—Docetaxel—melanoma	0.0836	0.147	CbGbCtD
Oxycodone—CYP3A4—Vemurafenib—melanoma	0.0712	0.126	CbGbCtD
Oxycodone—CYP3A5—Docetaxel—melanoma	0.0627	0.11	CbGbCtD
Oxycodone—CYP3A4—Docetaxel—melanoma	0.0244	0.0431	CbGbCtD
Oxycodone—Naloxone—TLR4—melanoma	0.00382	0.711	CrCbGaD
Oxycodone—Hyponatraemia—Docetaxel—melanoma	0.000669	0.00217	CcSEcCtD
Oxycodone—Visual impairment—Temozolomide—melanoma	0.000668	0.00216	CcSEcCtD
Oxycodone—Flushing—Carmustine—melanoma	0.000666	0.00216	CcSEcCtD
Oxycodone—Ill-defined disorder—Bleomycin—melanoma	0.000664	0.00215	CcSEcCtD
Oxycodone—Anaemia—Bleomycin—melanoma	0.000662	0.00214	CcSEcCtD
Oxycodone—Diarrhoea—Vemurafenib—melanoma	0.00066	0.00214	CcSEcCtD
Oxycodone—Migraine—Docetaxel—melanoma	0.000656	0.00212	CcSEcCtD
Oxycodone—Eye disorder—Temozolomide—melanoma	0.000648	0.0021	CcSEcCtD
Oxycodone—Tinnitus—Temozolomide—melanoma	0.000647	0.00209	CcSEcCtD
Oxycodone—Malaise—Bleomycin—melanoma	0.000645	0.00209	CcSEcCtD
Oxycodone—Flushing—Temozolomide—melanoma	0.000644	0.00208	CcSEcCtD
Oxycodone—Cardiac disorder—Temozolomide—melanoma	0.000644	0.00208	CcSEcCtD
Oxycodone—Leukopenia—Bleomycin—melanoma	0.000641	0.00207	CcSEcCtD
Oxycodone—Dizziness—Vemurafenib—melanoma	0.000638	0.00206	CcSEcCtD
Oxycodone—Angiopathy—Temozolomide—melanoma	0.000629	0.00204	CcSEcCtD
Oxycodone—Mental disorder—Carmustine—melanoma	0.000629	0.00204	CcSEcCtD
Oxycodone—Immune system disorder—Temozolomide—melanoma	0.000626	0.00203	CcSEcCtD
Oxycodone—Mediastinal disorder—Temozolomide—melanoma	0.000625	0.00202	CcSEcCtD
Oxycodone—Malnutrition—Carmustine—melanoma	0.000625	0.00202	CcSEcCtD
Oxycodone—Cough—Bleomycin—melanoma	0.000625	0.00202	CcSEcCtD
Oxycodone—Naltrexone—ABCB1—melanoma	0.000624	0.116	CrCbGaD
Oxycodone—Chills—Temozolomide—melanoma	0.000622	0.00201	CcSEcCtD
Oxycodone—Dehydration—Docetaxel—melanoma	0.00062	0.00201	CcSEcCtD
Oxycodone—Ill-defined disorder—Dactinomycin—melanoma	0.000619	0.002	CcSEcCtD
Oxycodone—Anaemia—Dactinomycin—melanoma	0.000617	0.002	CcSEcCtD
Oxycodone—Vomiting—Vemurafenib—melanoma	0.000613	0.00198	CcSEcCtD
Oxycodone—Dry skin—Docetaxel—melanoma	0.000611	0.00198	CcSEcCtD
Oxycodone—Myalgia—Bleomycin—melanoma	0.000609	0.00197	CcSEcCtD
Oxycodone—Chest pain—Bleomycin—melanoma	0.000609	0.00197	CcSEcCtD
Oxycodone—Orthostatic hypotension—Docetaxel—melanoma	0.000609	0.00197	CcSEcCtD
Oxycodone—Abdominal pain upper—Docetaxel—melanoma	0.000609	0.00197	CcSEcCtD
Oxycodone—Rash—Vemurafenib—melanoma	0.000608	0.00197	CcSEcCtD
Oxycodone—Mental disorder—Temozolomide—melanoma	0.000608	0.00197	CcSEcCtD
Oxycodone—Dermatitis—Vemurafenib—melanoma	0.000607	0.00197	CcSEcCtD
Oxycodone—Back pain—Carmustine—melanoma	0.000604	0.00196	CcSEcCtD
Oxycodone—Headache—Vemurafenib—melanoma	0.000604	0.00196	CcSEcCtD
Oxycodone—Malnutrition—Temozolomide—melanoma	0.000604	0.00195	CcSEcCtD
Oxycodone—Breast disorder—Docetaxel—melanoma	0.000602	0.00195	CcSEcCtD
Oxycodone—Discomfort—Bleomycin—melanoma	0.000602	0.00195	CcSEcCtD
Oxycodone—Malaise—Dactinomycin—melanoma	0.000602	0.00195	CcSEcCtD
Oxycodone—Leukopenia—Dactinomycin—melanoma	0.000598	0.00193	CcSEcCtD
Oxycodone—Nasopharyngitis—Docetaxel—melanoma	0.000596	0.00193	CcSEcCtD
Oxycodone—Dysgeusia—Temozolomide—melanoma	0.000591	0.00191	CcSEcCtD
Oxycodone—Confusional state—Bleomycin—melanoma	0.000589	0.00191	CcSEcCtD
Oxycodone—Tremor—Carmustine—melanoma	0.000585	0.00189	CcSEcCtD
Oxycodone—Anaphylactic shock—Bleomycin—melanoma	0.000584	0.00189	CcSEcCtD
Oxycodone—Oedema—Bleomycin—melanoma	0.000584	0.00189	CcSEcCtD
Oxycodone—Back pain—Temozolomide—melanoma	0.000584	0.00189	CcSEcCtD
Oxycodone—Infection—Bleomycin—melanoma	0.00058	0.00188	CcSEcCtD
Oxycodone—Anaemia—Carmustine—melanoma	0.000577	0.00187	CcSEcCtD
Oxycodone—Dysphagia—Docetaxel—melanoma	0.000576	0.00187	CcSEcCtD
Oxycodone—Agitation—Carmustine—melanoma	0.000574	0.00186	CcSEcCtD
Oxycodone—Nausea—Vemurafenib—melanoma	0.000573	0.00185	CcSEcCtD
Oxycodone—Myalgia—Dactinomycin—melanoma	0.000568	0.00184	CcSEcCtD
Oxycodone—Bronchospasm—Docetaxel—melanoma	0.000567	0.00183	CcSEcCtD
Oxycodone—Tremor—Temozolomide—melanoma	0.000566	0.00183	CcSEcCtD
Oxycodone—Discomfort—Dactinomycin—melanoma	0.000561	0.00182	CcSEcCtD
Oxycodone—Ill-defined disorder—Temozolomide—melanoma	0.00056	0.00181	CcSEcCtD
Oxycodone—Leukopenia—Carmustine—melanoma	0.000559	0.00181	CcSEcCtD
Oxycodone—Anaemia—Temozolomide—melanoma	0.000558	0.00181	CcSEcCtD
Oxycodone—Anorexia—Bleomycin—melanoma	0.000557	0.0018	CcSEcCtD
Oxycodone—Agitation—Temozolomide—melanoma	0.000555	0.0018	CcSEcCtD
Oxycodone—Angioedema—Temozolomide—melanoma	0.000552	0.00179	CcSEcCtD
Oxycodone—Hypotension—Bleomycin—melanoma	0.000546	0.00177	CcSEcCtD
Oxycodone—Oedema—Dactinomycin—melanoma	0.000545	0.00176	CcSEcCtD
Oxycodone—Malaise—Temozolomide—melanoma	0.000544	0.00176	CcSEcCtD
Oxycodone—Vertigo—Temozolomide—melanoma	0.000542	0.00176	CcSEcCtD
Oxycodone—Convulsion—Carmustine—melanoma	0.000541	0.00175	CcSEcCtD
Oxycodone—Infection—Dactinomycin—melanoma	0.000541	0.00175	CcSEcCtD
Oxycodone—Leukopenia—Temozolomide—melanoma	0.00054	0.00175	CcSEcCtD
Oxycodone—Palpitations—Temozolomide—melanoma	0.000534	0.00173	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Bleomycin—melanoma	0.000532	0.00172	CcSEcCtD
Oxycodone—Myalgia—Carmustine—melanoma	0.000532	0.00172	CcSEcCtD
Oxycodone—Chest pain—Carmustine—melanoma	0.000532	0.00172	CcSEcCtD
Oxycodone—Anxiety—Carmustine—melanoma	0.00053	0.00172	CcSEcCtD
Oxycodone—Cough—Temozolomide—melanoma	0.000527	0.00171	CcSEcCtD
Oxycodone—Paraesthesia—Bleomycin—melanoma	0.000525	0.0017	CcSEcCtD
Oxycodone—Convulsion—Temozolomide—melanoma	0.000523	0.00169	CcSEcCtD
Oxycodone—Weight decreased—Docetaxel—melanoma	0.000521	0.00169	CcSEcCtD
Oxycodone—Dyspnoea—Bleomycin—melanoma	0.000521	0.00169	CcSEcCtD
Oxycodone—Anorexia—Dactinomycin—melanoma	0.000519	0.00168	CcSEcCtD
Oxycodone—Pneumonia—Docetaxel—melanoma	0.000517	0.00167	CcSEcCtD
Oxycodone—Confusional state—Carmustine—melanoma	0.000514	0.00166	CcSEcCtD
Oxycodone—Arthralgia—Temozolomide—melanoma	0.000514	0.00166	CcSEcCtD
Oxycodone—Myalgia—Temozolomide—melanoma	0.000514	0.00166	CcSEcCtD
Oxycodone—Infestation NOS—Docetaxel—melanoma	0.000514	0.00166	CcSEcCtD
Oxycodone—Infestation—Docetaxel—melanoma	0.000514	0.00166	CcSEcCtD
Oxycodone—Anxiety—Temozolomide—melanoma	0.000512	0.00166	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00051	0.00165	CcSEcCtD
Oxycodone—Oedema—Carmustine—melanoma	0.00051	0.00165	CcSEcCtD
Oxycodone—Discomfort—Temozolomide—melanoma	0.000508	0.00164	CcSEcCtD
Oxycodone—Decreased appetite—Bleomycin—melanoma	0.000508	0.00164	CcSEcCtD
Oxycodone—Infection—Carmustine—melanoma	0.000507	0.00164	CcSEcCtD
Oxycodone—Dry mouth—Temozolomide—melanoma	0.000503	0.00163	CcSEcCtD
Oxycodone—Stomatitis—Docetaxel—melanoma	0.000501	0.00162	CcSEcCtD
Oxycodone—Pain—Bleomycin—melanoma	0.0005	0.00162	CcSEcCtD
Oxycodone—Tachycardia—Carmustine—melanoma	0.000498	0.00161	CcSEcCtD
Oxycodone—Confusional state—Temozolomide—melanoma	0.000497	0.00161	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000496	0.00161	CcSEcCtD
Oxycodone—Anaphylactic shock—Temozolomide—melanoma	0.000493	0.00159	CcSEcCtD
Oxycodone—Oedema—Temozolomide—melanoma	0.000493	0.00159	CcSEcCtD
Oxycodone—Infection—Temozolomide—melanoma	0.00049	0.00158	CcSEcCtD
Oxycodone—Anorexia—Carmustine—melanoma	0.000486	0.00157	CcSEcCtD
Oxycodone—Hepatobiliary disease—Docetaxel—melanoma	0.000486	0.00157	CcSEcCtD
Oxycodone—Epistaxis—Docetaxel—melanoma	0.000485	0.00157	CcSEcCtD
Oxycodone—Nervous system disorder—Temozolomide—melanoma	0.000483	0.00156	CcSEcCtD
Oxycodone—Feeling abnormal—Bleomycin—melanoma	0.000481	0.00156	CcSEcCtD
Oxycodone—Skin disorder—Temozolomide—melanoma	0.000479	0.00155	CcSEcCtD
Oxycodone—Naloxone—ALB—melanoma	0.000477	0.0887	CrCbGaD
Oxycodone—Hypotension—Carmustine—melanoma	0.000476	0.00154	CcSEcCtD
Oxycodone—Hyperhidrosis—Temozolomide—melanoma	0.000476	0.00154	CcSEcCtD
Oxycodone—Decreased appetite—Dactinomycin—melanoma	0.000474	0.00153	CcSEcCtD
Oxycodone—Fatigue—Dactinomycin—melanoma	0.00047	0.00152	CcSEcCtD
Oxycodone—Anorexia—Temozolomide—melanoma	0.00047	0.00152	CcSEcCtD
Oxycodone—Pain—Dactinomycin—melanoma	0.000466	0.00151	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Carmustine—melanoma	0.000465	0.0015	CcSEcCtD
Oxycodone—Urticaria—Bleomycin—melanoma	0.000464	0.0015	CcSEcCtD
Oxycodone—Haemoglobin—Docetaxel—melanoma	0.000464	0.0015	CcSEcCtD
Oxycodone—Rhinitis—Docetaxel—melanoma	0.000462	0.0015	CcSEcCtD
Oxycodone—Body temperature increased—Bleomycin—melanoma	0.000462	0.00149	CcSEcCtD
Oxycodone—Haemorrhage—Docetaxel—melanoma	0.000461	0.00149	CcSEcCtD
Oxycodone—Hepatitis—Docetaxel—melanoma	0.000461	0.00149	CcSEcCtD
Oxycodone—Insomnia—Carmustine—melanoma	0.000461	0.00149	CcSEcCtD
Oxycodone—Hypoaesthesia—Docetaxel—melanoma	0.000459	0.00149	CcSEcCtD
Oxycodone—Paraesthesia—Carmustine—melanoma	0.000458	0.00148	CcSEcCtD
Oxycodone—Pharyngitis—Docetaxel—melanoma	0.000458	0.00148	CcSEcCtD
Oxycodone—Urinary tract disorder—Docetaxel—melanoma	0.000455	0.00147	CcSEcCtD
Oxycodone—Naloxone—ABCB1—melanoma	0.000455	0.0847	CrCbGaD
Oxycodone—Dyspnoea—Carmustine—melanoma	0.000455	0.00147	CcSEcCtD
Oxycodone—Oedema peripheral—Docetaxel—melanoma	0.000454	0.00147	CcSEcCtD
Oxycodone—Somnolence—Carmustine—melanoma	0.000453	0.00147	CcSEcCtD
Oxycodone—Connective tissue disorder—Docetaxel—melanoma	0.000453	0.00147	CcSEcCtD
Oxycodone—Urethral disorder—Docetaxel—melanoma	0.000452	0.00146	CcSEcCtD
Oxycodone—Feeling abnormal—Dactinomycin—melanoma	0.000449	0.00145	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Temozolomide—melanoma	0.000449	0.00145	CcSEcCtD
Oxycodone—Insomnia—Temozolomide—melanoma	0.000446	0.00144	CcSEcCtD
Oxycodone—Gastrointestinal pain—Dactinomycin—melanoma	0.000445	0.00144	CcSEcCtD
Oxycodone—Visual impairment—Docetaxel—melanoma	0.000444	0.00144	CcSEcCtD
Oxycodone—Decreased appetite—Carmustine—melanoma	0.000443	0.00143	CcSEcCtD
Oxycodone—Paraesthesia—Temozolomide—melanoma	0.000442	0.00143	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Carmustine—melanoma	0.00044	0.00142	CcSEcCtD
Oxycodone—Dyspnoea—Temozolomide—melanoma	0.000439	0.00142	CcSEcCtD
Oxycodone—Somnolence—Temozolomide—melanoma	0.000438	0.00142	CcSEcCtD
Oxycodone—Pain—Carmustine—melanoma	0.000436	0.00141	CcSEcCtD
Oxycodone—Constipation—Carmustine—melanoma	0.000436	0.00141	CcSEcCtD
Oxycodone—Dyspepsia—Temozolomide—melanoma	0.000434	0.0014	CcSEcCtD
Oxycodone—Eye disorder—Docetaxel—melanoma	0.000431	0.0014	CcSEcCtD
Oxycodone—Abdominal pain—Dactinomycin—melanoma	0.000431	0.00139	CcSEcCtD
Oxycodone—Body temperature increased—Dactinomycin—melanoma	0.000431	0.00139	CcSEcCtD
Oxycodone—Hypersensitivity—Bleomycin—melanoma	0.00043	0.00139	CcSEcCtD
Oxycodone—Decreased appetite—Temozolomide—melanoma	0.000428	0.00139	CcSEcCtD
Oxycodone—Cardiac disorder—Docetaxel—melanoma	0.000428	0.00139	CcSEcCtD
Oxycodone—Flushing—Docetaxel—melanoma	0.000428	0.00139	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Temozolomide—melanoma	0.000425	0.00138	CcSEcCtD
Oxycodone—Fatigue—Temozolomide—melanoma	0.000425	0.00138	CcSEcCtD
Oxycodone—Pain—Temozolomide—melanoma	0.000421	0.00136	CcSEcCtD
Oxycodone—Constipation—Temozolomide—melanoma	0.000421	0.00136	CcSEcCtD
Oxycodone—Feeling abnormal—Carmustine—melanoma	0.00042	0.00136	CcSEcCtD
Oxycodone—Asthenia—Bleomycin—melanoma	0.000419	0.00136	CcSEcCtD
Oxycodone—Angiopathy—Docetaxel—melanoma	0.000418	0.00135	CcSEcCtD
Oxycodone—Gastrointestinal pain—Carmustine—melanoma	0.000417	0.00135	CcSEcCtD
Oxycodone—Immune system disorder—Docetaxel—melanoma	0.000417	0.00135	CcSEcCtD
Oxycodone—Mediastinal disorder—Docetaxel—melanoma	0.000416	0.00135	CcSEcCtD
Oxycodone—Chills—Docetaxel—melanoma	0.000414	0.00134	CcSEcCtD
Oxycodone—Pruritus—Bleomycin—melanoma	0.000413	0.00134	CcSEcCtD
Oxycodone—Feeling abnormal—Temozolomide—melanoma	0.000406	0.00131	CcSEcCtD
Oxycodone—Mental disorder—Docetaxel—melanoma	0.000404	0.00131	CcSEcCtD
Oxycodone—Abdominal pain—Carmustine—melanoma	0.000403	0.0013	CcSEcCtD
Oxycodone—Body temperature increased—Carmustine—melanoma	0.000403	0.0013	CcSEcCtD
Oxycodone—Gastrointestinal pain—Temozolomide—melanoma	0.000403	0.0013	CcSEcCtD
Oxycodone—Malnutrition—Docetaxel—melanoma	0.000402	0.0013	CcSEcCtD
Oxycodone—Hypersensitivity—Dactinomycin—melanoma	0.000401	0.0013	CcSEcCtD
Oxycodone—Dysgeusia—Docetaxel—melanoma	0.000393	0.00127	CcSEcCtD
Oxycodone—Urticaria—Temozolomide—melanoma	0.000391	0.00127	CcSEcCtD
Oxycodone—Asthenia—Dactinomycin—melanoma	0.000391	0.00127	CcSEcCtD
Oxycodone—Body temperature increased—Temozolomide—melanoma	0.00039	0.00126	CcSEcCtD
Oxycodone—Abdominal pain—Temozolomide—melanoma	0.00039	0.00126	CcSEcCtD
Oxycodone—Back pain—Docetaxel—melanoma	0.000388	0.00126	CcSEcCtD
Oxycodone—Muscle spasms—Docetaxel—melanoma	0.000386	0.00125	CcSEcCtD
Oxycodone—Hypersensitivity—Carmustine—melanoma	0.000376	0.00122	CcSEcCtD
Oxycodone—Diarrhoea—Dactinomycin—melanoma	0.000373	0.00121	CcSEcCtD
Oxycodone—Vomiting—Bleomycin—melanoma	0.000371	0.0012	CcSEcCtD
Oxycodone—Anaemia—Docetaxel—melanoma	0.000371	0.0012	CcSEcCtD
Oxycodone—Rash—Bleomycin—melanoma	0.000368	0.00119	CcSEcCtD
Oxycodone—Dermatitis—Bleomycin—melanoma	0.000368	0.00119	CcSEcCtD
Oxycodone—Asthenia—Carmustine—melanoma	0.000366	0.00118	CcSEcCtD
Oxycodone—Hypersensitivity—Temozolomide—melanoma	0.000363	0.00118	CcSEcCtD
Oxycodone—Syncope—Docetaxel—melanoma	0.00036	0.00117	CcSEcCtD
Oxycodone—Leukopenia—Docetaxel—melanoma	0.000359	0.00116	CcSEcCtD
Oxycodone—Palpitations—Docetaxel—melanoma	0.000355	0.00115	CcSEcCtD
Oxycodone—Asthenia—Temozolomide—melanoma	0.000354	0.00114	CcSEcCtD
Oxycodone—Loss of consciousness—Docetaxel—melanoma	0.000353	0.00114	CcSEcCtD
Oxycodone—Cough—Docetaxel—melanoma	0.00035	0.00113	CcSEcCtD
Oxycodone—Diarrhoea—Carmustine—melanoma	0.000349	0.00113	CcSEcCtD
Oxycodone—Pruritus—Temozolomide—melanoma	0.000349	0.00113	CcSEcCtD
Oxycodone—Convulsion—Docetaxel—melanoma	0.000348	0.00113	CcSEcCtD
Oxycodone—Nausea—Bleomycin—melanoma	0.000347	0.00112	CcSEcCtD
Oxycodone—Vomiting—Dactinomycin—melanoma	0.000346	0.00112	CcSEcCtD
Oxycodone—Rash—Dactinomycin—melanoma	0.000343	0.00111	CcSEcCtD
Oxycodone—Chest pain—Docetaxel—melanoma	0.000342	0.00111	CcSEcCtD
Oxycodone—Myalgia—Docetaxel—melanoma	0.000342	0.00111	CcSEcCtD
Oxycodone—Arthralgia—Docetaxel—melanoma	0.000342	0.00111	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000339	0.0011	CcSEcCtD
Oxycodone—Dizziness—Carmustine—melanoma	0.000337	0.00109	CcSEcCtD
Oxycodone—Diarrhoea—Temozolomide—melanoma	0.000337	0.00109	CcSEcCtD
Oxycodone—Dry mouth—Docetaxel—melanoma	0.000334	0.00108	CcSEcCtD
Oxycodone—Confusional state—Docetaxel—melanoma	0.00033	0.00107	CcSEcCtD
Oxycodone—Anaphylactic shock—Docetaxel—melanoma	0.000328	0.00106	CcSEcCtD
Oxycodone—Oedema—Docetaxel—melanoma	0.000328	0.00106	CcSEcCtD
Oxycodone—Dizziness—Temozolomide—melanoma	0.000326	0.00105	CcSEcCtD
Oxycodone—Infection—Docetaxel—melanoma	0.000326	0.00105	CcSEcCtD
Oxycodone—Vomiting—Carmustine—melanoma	0.000324	0.00105	CcSEcCtD
Oxycodone—Nausea—Dactinomycin—melanoma	0.000324	0.00105	CcSEcCtD
Oxycodone—Shock—Docetaxel—melanoma	0.000322	0.00104	CcSEcCtD
Oxycodone—Rash—Carmustine—melanoma	0.000321	0.00104	CcSEcCtD
Oxycodone—Nervous system disorder—Docetaxel—melanoma	0.000321	0.00104	CcSEcCtD
Oxycodone—Dermatitis—Carmustine—melanoma	0.000321	0.00104	CcSEcCtD
Oxycodone—Tachycardia—Docetaxel—melanoma	0.00032	0.00104	CcSEcCtD
Oxycodone—Headache—Carmustine—melanoma	0.000319	0.00103	CcSEcCtD
Oxycodone—Skin disorder—Docetaxel—melanoma	0.000318	0.00103	CcSEcCtD
Oxycodone—Vomiting—Temozolomide—melanoma	0.000313	0.00101	CcSEcCtD
Oxycodone—Anorexia—Docetaxel—melanoma	0.000312	0.00101	CcSEcCtD
Oxycodone—Rash—Temozolomide—melanoma	0.000311	0.00101	CcSEcCtD
Oxycodone—Dermatitis—Temozolomide—melanoma	0.00031	0.001	CcSEcCtD
Oxycodone—Headache—Temozolomide—melanoma	0.000309	0.000999	CcSEcCtD
Oxycodone—Hypotension—Docetaxel—melanoma	0.000306	0.000991	CcSEcCtD
Oxycodone—Nausea—Carmustine—melanoma	0.000303	0.00098	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Docetaxel—melanoma	0.000299	0.000966	CcSEcCtD
Oxycodone—Insomnia—Docetaxel—melanoma	0.000296	0.000959	CcSEcCtD
Oxycodone—Paraesthesia—Docetaxel—melanoma	0.000294	0.000952	CcSEcCtD
Oxycodone—Nausea—Temozolomide—melanoma	0.000293	0.000947	CcSEcCtD
Oxycodone—Dyspnoea—Docetaxel—melanoma	0.000292	0.000946	CcSEcCtD
Oxycodone—Somnolence—Docetaxel—melanoma	0.000291	0.000943	CcSEcCtD
Oxycodone—Dyspepsia—Docetaxel—melanoma	0.000288	0.000934	CcSEcCtD
Oxycodone—Decreased appetite—Docetaxel—melanoma	0.000285	0.000922	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Docetaxel—melanoma	0.000283	0.000916	CcSEcCtD
Oxycodone—Fatigue—Docetaxel—melanoma	0.000283	0.000914	CcSEcCtD
Oxycodone—Pain—Docetaxel—melanoma	0.00028	0.000907	CcSEcCtD
Oxycodone—Constipation—Docetaxel—melanoma	0.00028	0.000907	CcSEcCtD
Oxycodone—Feeling abnormal—Docetaxel—melanoma	0.00027	0.000874	CcSEcCtD
Oxycodone—Gastrointestinal pain—Docetaxel—melanoma	0.000268	0.000867	CcSEcCtD
Oxycodone—Abdominal pain—Docetaxel—melanoma	0.000259	0.000838	CcSEcCtD
Oxycodone—Body temperature increased—Docetaxel—melanoma	0.000259	0.000838	CcSEcCtD
Oxycodone—Hypersensitivity—Docetaxel—melanoma	0.000241	0.000781	CcSEcCtD
Oxycodone—Asthenia—Docetaxel—melanoma	0.000235	0.000761	CcSEcCtD
Oxycodone—Pruritus—Docetaxel—melanoma	0.000232	0.00075	CcSEcCtD
Oxycodone—Diarrhoea—Docetaxel—melanoma	0.000224	0.000726	CcSEcCtD
Oxycodone—Dizziness—Docetaxel—melanoma	0.000217	0.000701	CcSEcCtD
Oxycodone—Vomiting—Docetaxel—melanoma	0.000208	0.000674	CcSEcCtD
Oxycodone—Rash—Docetaxel—melanoma	0.000207	0.000669	CcSEcCtD
Oxycodone—Dermatitis—Docetaxel—melanoma	0.000206	0.000668	CcSEcCtD
Oxycodone—Headache—Docetaxel—melanoma	0.000205	0.000664	CcSEcCtD
Oxycodone—Nausea—Docetaxel—melanoma	0.000195	0.00063	CcSEcCtD
Oxycodone—OPRK1—Signaling Pathways—TERT—melanoma	2.48e-05	0.00021	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RAC1—melanoma	2.48e-05	0.00021	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PLA2G6—melanoma	2.47e-05	0.000209	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOTCH1—melanoma	2.44e-05	0.000207	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC6A11—melanoma	2.43e-05	0.000206	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIP4K2A—melanoma	2.43e-05	0.000206	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—FASN—melanoma	2.43e-05	0.000206	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CD86—melanoma	2.43e-05	0.000206	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CXCL8—melanoma	2.43e-05	0.000205	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EDN1—melanoma	2.41e-05	0.000204	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SLC5A5—melanoma	2.39e-05	0.000202	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CD80—melanoma	2.39e-05	0.000202	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—APC—melanoma	2.39e-05	0.000202	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—KIT—melanoma	2.39e-05	0.000202	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CG—melanoma	2.39e-05	0.000202	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—NRAS—melanoma	2.39e-05	0.000202	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HIF1A—melanoma	2.38e-05	0.000201	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MTAP—melanoma	2.37e-05	0.0002	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EGF—melanoma	2.36e-05	0.0002	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CSF2—melanoma	2.36e-05	0.000199	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FGF1—melanoma	2.36e-05	0.000199	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PRKCA—melanoma	2.32e-05	0.000197	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—IL2—melanoma	2.32e-05	0.000196	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GNAQ—melanoma	2.31e-05	0.000196	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CD44—melanoma	2.31e-05	0.000196	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—E2F1—melanoma	2.3e-05	0.000195	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ERCC2—melanoma	2.3e-05	0.000195	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CB—melanoma	2.29e-05	0.000194	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—MAPK3—melanoma	2.29e-05	0.000193	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PDGFRA—melanoma	2.28e-05	0.000193	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KDR—melanoma	2.27e-05	0.000192	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ITGB3—melanoma	2.26e-05	0.000191	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PRKCA—melanoma	2.26e-05	0.000191	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—BRAF—melanoma	2.24e-05	0.00019	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—VCAN—melanoma	2.22e-05	0.000188	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP1B1—melanoma	2.22e-05	0.000187	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SPP1—melanoma	2.21e-05	0.000187	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAP2K2—melanoma	2.21e-05	0.000187	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCL8—melanoma	2.2e-05	0.000187	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FN1—melanoma	2.19e-05	0.000185	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IGF1—melanoma	2.18e-05	0.000185	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—MAPK1—melanoma	2.17e-05	0.000184	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—EGFR—melanoma	2.17e-05	0.000184	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOTCH1—melanoma	2.14e-05	0.000181	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MAP2K1—melanoma	2.11e-05	0.000179	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PHGDH—melanoma	2.11e-05	0.000178	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LUM—melanoma	2.11e-05	0.000178	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL2—melanoma	2.11e-05	0.000178	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TERT—melanoma	2.1e-05	0.000178	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CD—melanoma	2.1e-05	0.000178	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CD80—melanoma	2.1e-05	0.000177	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RAC1—melanoma	2.09e-05	0.000177	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—APC—melanoma	2.09e-05	0.000177	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KIT—melanoma	2.09e-05	0.000177	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CG—melanoma	2.09e-05	0.000177	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—NRAS—melanoma	2.09e-05	0.000177	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—PIK3CA—melanoma	2.08e-05	0.000176	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EGF—melanoma	2.07e-05	0.000175	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HPSE—melanoma	2.07e-05	0.000175	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—KRAS—melanoma	2.05e-05	0.000174	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CUBN—melanoma	2.03e-05	0.000172	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—FGF2—melanoma	2.01e-05	0.00017	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HIF1A—melanoma	2.01e-05	0.00017	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—MAPK3—melanoma	2e-05	0.00017	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—BRAF—melanoma	1.97e-05	0.000166	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—BSG—melanoma	1.96e-05	0.000166	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CSPG4—melanoma	1.96e-05	0.000166	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SDHD—melanoma	1.96e-05	0.000166	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KDR—melanoma	1.92e-05	0.000162	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IGF1—melanoma	1.92e-05	0.000162	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—MAPK1—melanoma	1.91e-05	0.000161	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—EGFR—melanoma	1.91e-05	0.000161	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GPAM—melanoma	1.9e-05	0.000161	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PIK3CA—melanoma	1.89e-05	0.00016	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MDM2—melanoma	1.88e-05	0.000159	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP17A1—melanoma	1.87e-05	0.000158	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ERBB2—melanoma	1.85e-05	0.000157	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAP2K1—melanoma	1.85e-05	0.000157	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FN1—melanoma	1.85e-05	0.000156	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CD—melanoma	1.84e-05	0.000156	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CB—melanoma	1.83e-05	0.000155	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ABCB1—melanoma	1.82e-05	0.000154	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PIK3CA—melanoma	1.82e-05	0.000154	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CG—melanoma	1.82e-05	0.000154	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOTCH1—melanoma	1.81e-05	0.000153	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—KRAS—melanoma	1.8e-05	0.000152	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CD80—melanoma	1.77e-05	0.00015	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KIT—melanoma	1.77e-05	0.00015	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CG—melanoma	1.77e-05	0.00015	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APC—melanoma	1.77e-05	0.00015	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—NRAS—melanoma	1.77e-05	0.00015	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GNA11—melanoma	1.77e-05	0.00015	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FGF2—melanoma	1.76e-05	0.000149	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCL8—melanoma	1.76e-05	0.000149	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PPARG—melanoma	1.76e-05	0.000149	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EGF—melanoma	1.75e-05	0.000148	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HRAS—melanoma	1.75e-05	0.000148	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—FASN—melanoma	1.73e-05	0.000146	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CDKN1B—melanoma	1.72e-05	0.000145	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SLC5A5—melanoma	1.7e-05	0.000144	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—AKT1—melanoma	1.7e-05	0.000144	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—MAPK3—melanoma	1.69e-05	0.000143	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CASP3—melanoma	1.68e-05	0.000142	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL2—melanoma	1.68e-05	0.000142	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PRKCA—melanoma	1.68e-05	0.000142	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL6—melanoma	1.67e-05	0.000141	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ERCC2—melanoma	1.66e-05	0.000141	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—BRAF—melanoma	1.66e-05	0.000141	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CA—melanoma	1.65e-05	0.00014	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MDM2—melanoma	1.65e-05	0.000139	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GNAQ—melanoma	1.64e-05	0.000139	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CD44—melanoma	1.64e-05	0.000139	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCND1—melanoma	1.64e-05	0.000139	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ERBB2—melanoma	1.62e-05	0.000137	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CTNNB1—melanoma	1.62e-05	0.000137	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IGF1—melanoma	1.62e-05	0.000137	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PLA2G6—melanoma	1.61e-05	0.000137	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—MAPK1—melanoma	1.61e-05	0.000136	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—EGFR—melanoma	1.61e-05	0.000136	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CB—melanoma	1.6e-05	0.000136	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CD—melanoma	1.6e-05	0.000135	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MMP9—melanoma	1.59e-05	0.000134	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CDKN1A—melanoma	1.58e-05	0.000134	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PTEN—melanoma	1.58e-05	0.000134	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ALB—melanoma	1.58e-05	0.000134	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP1B1—melanoma	1.58e-05	0.000133	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NFKB1—melanoma	1.57e-05	0.000133	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAP2K1—melanoma	1.57e-05	0.000132	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CD—melanoma	1.55e-05	0.000132	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—AKT1—melanoma	1.54e-05	0.00013	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCL8—melanoma	1.54e-05	0.00013	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CA—melanoma	1.54e-05	0.00013	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HRAS—melanoma	1.53e-05	0.00013	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—KRAS—melanoma	1.52e-05	0.000129	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CDKN1B—melanoma	1.5e-05	0.000127	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FGF2—melanoma	1.49e-05	0.000126	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—AKT1—melanoma	1.49e-05	0.000126	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CASP3—melanoma	1.47e-05	0.000125	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL2—melanoma	1.47e-05	0.000125	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6—melanoma	1.47e-05	0.000124	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—VCAN—melanoma	1.45e-05	0.000123	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCND1—melanoma	1.44e-05	0.000121	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—VEGFA—melanoma	1.43e-05	0.000121	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CTNNB1—melanoma	1.42e-05	0.00012	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—STAT3—melanoma	1.41e-05	0.00012	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NRAS—melanoma	1.41e-05	0.000119	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CA—melanoma	1.4e-05	0.000118	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CB—melanoma	1.39e-05	0.000118	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MMP9—melanoma	1.39e-05	0.000118	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MDM2—melanoma	1.39e-05	0.000118	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CDKN1A—melanoma	1.39e-05	0.000118	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTEN—melanoma	1.39e-05	0.000117	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTGS2—melanoma	1.38e-05	0.000117	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NFKB1—melanoma	1.38e-05	0.000117	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ERBB2—melanoma	1.37e-05	0.000116	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CB—melanoma	1.36e-05	0.000115	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—AKT1—melanoma	1.35e-05	0.000114	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MAPK3—melanoma	1.35e-05	0.000114	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CG—melanoma	1.31e-05	0.000111	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MYC—melanoma	1.31e-05	0.000111	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCL8—melanoma	1.3e-05	0.00011	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ABCB1—melanoma	1.3e-05	0.00011	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HRAS—melanoma	1.29e-05	0.000109	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MAPK1—melanoma	1.28e-05	0.000109	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EGFR—melanoma	1.28e-05	0.000109	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CDKN1B—melanoma	1.27e-05	0.000108	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARG—melanoma	1.27e-05	0.000107	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—AKT1—melanoma	1.26e-05	0.000106	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—VEGFA—melanoma	1.25e-05	0.000106	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CASP3—melanoma	1.25e-05	0.000105	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL2—melanoma	1.24e-05	0.000105	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—STAT3—melanoma	1.24e-05	0.000105	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6—melanoma	1.24e-05	0.000105	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NRAS—melanoma	1.24e-05	0.000105	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP17A1—melanoma	1.22e-05	0.000104	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—KRAS—melanoma	1.21e-05	0.000103	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCND1—melanoma	1.21e-05	0.000103	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTEN—melanoma	1.2e-05	0.000102	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CTNNB1—melanoma	1.2e-05	0.000102	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PRKCA—melanoma	1.19e-05	0.000101	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ERCC2—melanoma	1.18e-05	0.0001	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAPK3—melanoma	1.18e-05	0.0001	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MMP9—melanoma	1.18e-05	9.97e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CDKN1A—melanoma	1.17e-05	9.93e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTEN—melanoma	1.17e-05	9.91e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NFKB1—melanoma	1.17e-05	9.86e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CD—melanoma	1.16e-05	9.78e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GNA11—melanoma	1.16e-05	9.78e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MYC—melanoma	1.15e-05	9.74e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—AKT1—melanoma	1.14e-05	9.67e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ALB—melanoma	1.14e-05	9.66e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—FASN—melanoma	1.13e-05	9.57e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAPK1—melanoma	1.13e-05	9.53e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EGFR—melanoma	1.13e-05	9.53e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CA—melanoma	1.11e-05	9.43e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC5A5—melanoma	1.11e-05	9.41e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TP53—melanoma	1.08e-05	9.13e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GNAQ—melanoma	1.07e-05	9.09e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CD44—melanoma	1.07e-05	9.09e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KRAS—melanoma	1.06e-05	9e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—VEGFA—melanoma	1.06e-05	8.95e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—STAT3—melanoma	1.05e-05	8.86e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NRAS—melanoma	1.04e-05	8.84e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HRAS—melanoma	1.03e-05	8.73e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP1B1—melanoma	1.03e-05	8.71e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CB—melanoma	1.01e-05	8.53e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAPK3—melanoma	1e-05	8.47e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS2—melanoma	9.98e-06	8.45e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6—melanoma	9.87e-06	8.35e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CA—melanoma	9.77e-06	8.27e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MYC—melanoma	9.73e-06	8.23e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAPK1—melanoma	9.52e-06	8.06e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EGFR—melanoma	9.52e-06	8.05e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TP53—melanoma	9.46e-06	8e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CG—melanoma	9.35e-06	7.91e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKT1—melanoma	9.11e-06	7.71e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HRAS—melanoma	9.04e-06	7.65e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARG—melanoma	9.02e-06	7.64e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KRAS—melanoma	8.99e-06	7.61e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTEN—melanoma	8.71e-06	7.37e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6—melanoma	8.66e-06	7.32e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CA—melanoma	8.5e-06	7.19e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCB1—melanoma	8.48e-06	7.18e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CA—melanoma	8.26e-06	6.99e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CD—melanoma	8.22e-06	6.96e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALB—melanoma	8.11e-06	6.87e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TP53—melanoma	7.99e-06	6.76e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKT1—melanoma	7.98e-06	6.76e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PRKCA—melanoma	7.8e-06	6.6e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ERCC2—melanoma	7.74e-06	6.55e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HRAS—melanoma	7.64e-06	6.47e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6—melanoma	7.32e-06	6.19e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CB—melanoma	7.16e-06	6.06e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS2—melanoma	7.1e-06	6.01e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AKT1—melanoma	6.94e-06	5.87e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKT1—melanoma	6.75e-06	5.71e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTEN—melanoma	6.19e-06	5.24e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CA—melanoma	6.14e-06	5.2e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CG—melanoma	6.11e-06	5.17e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARG—melanoma	5.9e-06	4.99e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CD—melanoma	5.37e-06	4.55e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALB—melanoma	5.3e-06	4.49e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AKT1—melanoma	5.02e-06	4.25e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CB—melanoma	4.68e-06	3.96e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS2—melanoma	4.64e-06	3.93e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CA—melanoma	4.37e-06	3.7e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTEN—melanoma	4.05e-06	3.43e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AKT1—melanoma	3.57e-06	3.02e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CA—melanoma	2.86e-06	2.42e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKT1—melanoma	2.33e-06	1.97e-05	CbGpPWpGaD
